You can buy or sell TrovaGene and other stocks, options, ETFs, and crypto commission-free!
TrovaGene, Inc. Common Stock, also called TrovaGene, is a clinical-stage, precision medicine oncology therapeutics company. Read More Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky and Hovsep Melkonyan on August 4, 1999 and is headquartered in San Diego, CA.
San Diego, Nevada
52 Week High
52 Week Low
Expected Mar 5, After Hours